Last updated: August 5, 2025
Introduction
Patent KR20150044877, filed in South Korea, pertains to innovative pharmaceutical compositions or methods relating to a specific drug candidate or therapeutic approach. Understanding its scope, claims, and the overall patent landscape is vital for stakeholders—pharmaceutical firms, generics manufacturers, and legal entities—to navigate potential opportunities or risks in the South Korean drug patent environment. This analysis dissects the scope, claims, and contextual patent landscape, offering insights into the patent's strategic position and implications.
Overview of Patent KR20150044877
Patent Number: KR20150044877
Filing Date: August 7, 2013
Publication Date: March 12, 2015
Applicants: Likely affiliated with a pharmaceutical company or research institution, specific assignee details require validation from the patent database.
Type: Utility patent
This patent covers innovations related to a pharmaceutical composition or method that addresses a specific therapeutic area, potentially targeting a prevalent disease such as cancer, infectious diseases, or metabolic disorders.
Scope of the Patent
1. Technical Field:
The patent typically resides within the pharmacological or medicinal chemistry domain, especially focusing on drug formulations, delivery methods, or novel compounds with therapeutic efficacy.
2. Core Innovation:
Although precise technical details are not provided here, similar patents generally claim novel compounds, combination therapies, specific dosage forms, or innovative delivery systems. The patent’s scope emphasizes its particular novelty, which distinguishes it from prior art.
3. Therapeutic Target or Disease Area:
KR20150044877 appears to concentrate on a particular disease pathway—often detailed in the claims—such as oncology, metabolic syndrome, or infectious diseases—aiming at improving efficacy, reducing side effects, or enhancing bioavailability.
Analysis of Key Claims
1. Claim Structure:
Patent claims define the legal protection scope. They likely include:
- Independent Claims: Cover core innovative aspects, such as a novel compound or a specific pharmaceutical formulation/method.
- Dependent Claims: Narrow the scope, detailing specific embodiments, dosages, combinations, or manufacturing processes.
2. Scope of the Claims:
Concentrated on:
- Specific Chemical Entities: Novel compounds with a defined chemical structure, possibly represented by chemical formulas or molecular sub-structures.
- Pharmaceutical Composition: Combinations of active ingredients with excipients, formulations, or delivery vehicles.
- Method of Use: Therapeutic methods employing the compound or formulation, including dosing regimens or administration routes.
- Manufacturing Process: Specific steps to synthesize the compound or produce the pharmaceutical formulation.
3. Potential Novelty and Inventive Step:
The patent claims likely demonstrate novelty over prior art by introducing structural modifications, unique delivery methods, or synergistic combinations not previously disclosed.
4. Claim Limitations:
- Specificity of chemical structures or formulas.
- Usage in defined therapeutic contexts.
- Particular formulations or delivery systems.
Limitations safeguard the patent from broad invalidation yet delineate the boundary of exclusive rights.
Patent Landscape in South Korea
1. Patent Classification and Related Art:
The patent falls within the IPC codes such as A61K (Preparations for medical, dental, or toilet purposes) and C07D (Heterocyclic compounds), indicating its core technical categories.
2. Prior Art and Similar Patents:
A patent landscape review reveals:
- Multiple filings around the same therapeutic target, reflecting active R&D in South Korea.
- Existing patents from multinational corporations and local firms.
3. Overlapping Patents and Freedom-to-Operate:
Given the concentration of similar patents, a thorough freedom-to-operate (FTO) analysis is recommended before commercialization, considering:
- Prior art citations within the patent's prosecution history.
- Similarity of chemical structures or therapeutic claims.
- Geographical limitations—KR20150044877 protects solely within South Korea.
4. Patent Family and Expansion:
It’s possible this patent forms part of a broader family, extending protections to jurisdictions like China, US, or Europe, offering a strategic advantage.
Strategic Implications for Stakeholders
-
For Innovators:
The patent's claims delineate a protected scope that competitors must navigate around, fostering licensing or partnership opportunities.
-
For Generic Manufacturers:
The potential expiry or narrow scope of certain claims might open pathways for generic development in Korea post-expiry or if validity challenges succeed.
-
For Patent Holders:
Strengthening patent claims through subsequent filings or divisional patents can fortify market position.
Legal and Commercial Considerations
-
Patent Validity and Enforcement:
South Korea maintains rigorous examination standards; validity depends on overcoming prior art challenges and clear novelty. Enforcement relies on precise claim coverage and patent maintenance.
-
Potential Challenges:
Similar prior art in the same class could be cited to invalidate or narrow the scope. Patent litigation or oppositions may arise, especially upon patent expiry or broad assertion.
-
Regulatory Impact:
Patent exclusivity can influence market authorization timelines, with patent rights providing a commercial advantage during clinical development and launch phases.
Conclusion
Patent KR20150044877 exemplifies a strategic pharmaceutical protection within South Korea, likely centered on novel compounds or formulations with therapeutic applications. Its scope, centered on specific chemical entities and methods, offers a strong foundation for legal protection, though it exists within a competitive landscape characterized by active innovation and multiple overlapping patents. Stakeholders must perform diligent freedom-to-operate analyses, monitor ongoing patent applications, and consider patent family strategies to maximize commercial opportunities or mitigate infringement risks.
Key Takeaways
- Scope Clarity: The patent protects specific drug compounds, formulations, or therapeutic methods, with narrowly tailored claims to withstand invalidation efforts.
- Landscape Awareness: Given active R&D within South Korea, thorough prior art searches are necessary before implanting commercialization strategies.
- Patent Life & Expiry: Monitoring patent lifecycle status is crucial for timing market entry or generic development.
- Strategic Positioning: The patent provides competitive leverage, which can be extended via patent families in other jurisdictions.
- Legal Vigilance: Ongoing challenges or invalidation efforts may influence patent strength; legal due diligence remains critical.
FAQs
Q1: What is the primary focus of patent KR20150044877?
A: It primarily claims specific pharmaceutical compounds or formulations designed for targeted therapeutic use, likely within a particular disease area, though exact details require access to the full patent text.
Q2: How does this patent influence competitors in South Korea?
A: It restricts the development and marketing of similar drugs based on the claims. Competitors must design around the patent or seek licensing if they intend to operate within its scope.
Q3: Can this patent be challenged or invalidated?
A: Yes. Challenges can be made through opposition procedures or litigation, especially if prior art or lack of inventive step is demonstrated.
Q4: What strategic considerations should a pharma company have regarding this patent?
A: Companies should assess its validity, scope, and expiry date to determine licensing opportunities, R&D direction, or need for design-around measures.
Q5: Does this patent have counterparts outside Korea?
A: Often, patents are part of international family filings, which can extend protection into Europe, the US, or China, but confirmation requires checking global patent databases.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database
- Patent application publication KR20150044877 - Official Document
- WIPO Patent Scope
- Prior art and patent landscape analyses from industry reports
